Bifunctional peroxisomal enzyme deficiency: genes and variants
Explore variant evidence for Bifunctional peroxisomal enzyme deficiency across 1 analyzed protein (HSD17B4). Linked ClinVar records include 33 pathogenic or likely pathogenic variants, 174 variants of uncertain significance and 38 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.
Data updated 2026-11-05. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Bifunctional peroxisomal enzyme deficiency
HSD17B4: Peroxisomal multifunctional enzyme type 2
A peroxisomal multifunctional enzyme that carries out two steps in fatty-acid beta-oxidation. It processes straight-chain and branched fatty acids as well as bile-acid intermediates, and loss of the protein causes D-bifunctional protein deficiency.
33 ClinVar pathogenic / likely pathogenic and 212 uncertain variants in HSD17B4 have source records linked to Bifunctional peroxisomal enzyme deficiency. Association strength is not clinical gene validity.
Where Bifunctional peroxisomal enzyme deficiency variants cluster
- HSD17B4 (3R)-hydroxyacyl-CoA dehydrogenase (positions 1–305): 20 of 31 ClinVar pathogenic / likely pathogenic variants, 1.6× more than its size predicts (a length-based count, not a validated hotspot).
ClinVar pathogenic and likely pathogenic variants linked to Bifunctional peroxisomal enzyme deficiency
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| HSD17B4 R248C | 248 | (3R)-hydroxyacyl-CoA dehydrogenase | Pathogenic / likely pathogenic (★★) |
| HSD17B4 H406Y | 406 | Enoyl-CoA hydratase 2 | Pathogenic / likely pathogenic (★★) |
| HSD17B4 H406R | 406 | Enoyl-CoA hydratase 2 | Pathogenic / likely pathogenic (★★) |
| HSD17B4 L405P | 405 | Enoyl-CoA hydratase 2 | Pathogenic / likely pathogenic (★★) |
| HSD17B4 N457Y | 457 | Enoyl-CoA hydratase 2 | Pathogenic / likely pathogenic (★★) |
| HSD17B4 R506C | 506 | MaoC-like | Pathogenic / likely pathogenic (★★) |
| HSD17B4 R506H | 506 | MaoC-like | Pathogenic / likely pathogenic (★★) |
| HSD17B4 N457D | 457 | Enoyl-CoA hydratase 2 | Pathogenic / likely pathogenic (★★) |
| HSD17B4 D117V | 117 | (3R)-hydroxyacyl-CoA dehydrogenase | Pathogenic / likely pathogenic (★★) |
| HSD17B4 W273C | 273 | (3R)-hydroxyacyl-CoA dehydrogenase | Pathogenic / likely pathogenic (★★) |
| HSD17B4 I516T | 516 | MaoC-like | Pathogenic / likely pathogenic (★★) |
| HSD17B4 A34V | 34 | (3R)-hydroxyacyl-CoA dehydrogenase | Pathogenic / likely pathogenic (★★) |
| HSD17B4 N176D | 176 | (3R)-hydroxyacyl-CoA dehydrogenase | Pathogenic / likely pathogenic (★★) |
| HSD17B4 V218L | 218 | (3R)-hydroxyacyl-CoA dehydrogenase | Pathogenic / likely pathogenic (★★) |
| HSD17B4 S372F | 372 | Enoyl-CoA hydratase 2 | Pathogenic / likely pathogenic (★★) |
| HSD17B4 H515R | 515 | MaoC-like | Pathogenic / likely pathogenic (★★) |
| HSD17B4 L736H | 736 | SCP2 | Pathogenic / likely pathogenic (★★) |
| HSD17B4 N98D | 98 | (3R)-hydroxyacyl-CoA dehydrogenase | Pathogenic / likely pathogenic (★) |
| HSD17B4 N98K | 98 | (3R)-hydroxyacyl-CoA dehydrogenase | Pathogenic / likely pathogenic (★) |
| HSD17B4 N98I | 98 | (3R)-hydroxyacyl-CoA dehydrogenase | Pathogenic / likely pathogenic (★) |
| HSD17B4 R248L | 248 | (3R)-hydroxyacyl-CoA dehydrogenase | Pathogenic / likely pathogenic (★) |
| HSD17B4 R251L | 251 | (3R)-hydroxyacyl-CoA dehydrogenase | Pathogenic / likely pathogenic (★) |
| HSD17B4 M1I | 1 | (3R)-hydroxyacyl-CoA dehydrogenase | Pathogenic / likely pathogenic (★) |
| HSD17B4 L5R | 5 | (3R)-hydroxyacyl-CoA dehydrogenase | Pathogenic / likely pathogenic (★) |
| HSD17B4 A100S | 100 | (3R)-hydroxyacyl-CoA dehydrogenase | Pathogenic / likely pathogenic (★) |
| HSD17B4 W135R | 135 | (3R)-hydroxyacyl-CoA dehydrogenase | Pathogenic / likely pathogenic (★) |
| HSD17B4 A196E | 196 | (3R)-hydroxyacyl-CoA dehydrogenase | Pathogenic / likely pathogenic (★) |
| HSD17B4 G254R | 254 | (3R)-hydroxyacyl-CoA dehydrogenase | Pathogenic / likely pathogenic (★) |
| HSD17B4 M1L | 1 | (3R)-hydroxyacyl-CoA dehydrogenase | Pathogenic / likely pathogenic (★) |
| HSD17B4 T15A | 15 | (3R)-hydroxyacyl-CoA dehydrogenase | Pathogenic / likely pathogenic (★) |
| HSD17B4 H532R | 532 | MaoC-like | Pathogenic / likely pathogenic (★) |
| HSD17B4 A175T | 175 | (3R)-hydroxyacyl-CoA dehydrogenase | Pathogenic / likely pathogenic (★) |
| HSD17B4 R106P | 106 | (3R)-hydroxyacyl-CoA dehydrogenase | Pathogenic / likely pathogenic |
Uncertain variants prioritized for review in Bifunctional peroxisomal enzyme deficiency
| Variant | Position | Protein part | Clinical label | Evidence |
|---|---|---|---|---|
| HSD17B4 A196V | 196 | (3R)-hydroxyacyl-CoA dehydrogenase | Conflicting reports (★) | +6: A196E at the same position is pathogenic; REVEL 0.945 |
| HSD17B4 N98S | 98 | (3R)-hydroxyacyl-CoA dehydrogenase | Conflicting reports (★) | +6: 4 other pathogenic changes within 3 positions; N98K at the same position is pathogenic; REVEL 0.842 |
| HSD17B4 L405F | 405 | Enoyl-CoA hydratase 2 | Uncertain (★★) | +6: 3 other pathogenic changes within 3 positions; L405P at the same position is pathogenic; REVEL 0.782 |
Which prediction tools work for Bifunctional peroxisomal enzyme deficiency
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- CATVariant: 100 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- REVEL: 99 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaLR: 99 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaSVM: 99 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- SIFT: 99 out of 100
- PolyPhen-2: 98 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- AlphaMissense: 97 out of 100
- ESM1b (LLR): 96 out of 100
- MutPred: 96 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- CADD: 87 out of 100
- phyloP: 86 out of 100
- SpliceAI: 65 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- Pangolin: 40 out of 100 (learned from overlapping clinical labels, so this is optimistic)
Diseases related to Bifunctional peroxisomal enzyme deficiency
- Perrault syndrome, also linked to HSD17B4
Frequently asked questions
Which genes have records linked to Bifunctional peroxisomal enzyme deficiency?
This view contains 1 analyzed proteins: HSD17B4. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 33 pathogenic or likely pathogenic variants, 174 variants of uncertain significance and 38 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 3 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 255 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center